We explored the properties of a catenary model that includes the basolateral (B), apical (A), and cellular compartments via simulations under linear and nonlinear conditions to understand the asymmetric observations arising from transporters, enzymes, and permeability in Caco-2 cells. The efflux ratio (EfR; P app,B3A / P app,A3B ), obtained from the effective permeability from the A3B and B3A direction under linear conditions, was unity for passively permeable drugs whose transport does not involve transporters; the value was unaffected by cellular binding or metabolism, but increased with apical efflux. Metabolism was asymmetric, showing lesser metabolite accrual for the B3A than A3B direction because of inherent differences in the volumes for A and B. Moreover, the net flux (total ؊ passive permeation) due to saturable apical efflux, absorption, or metabolism showed nonconformity to simple The majority of drugs available on the market are in oral dosage forms. For the assessment of permeability and oral drug absorption, in silico models (Stenberg et al., 2001 ) and high throughput systems, such as the parallel artificial membrane permeability assay (Kansy et al., 1998) and cell-based systems (Hidalgo et al., 1989) exist to relate drug permeability to absorption, especially for compounds that do not undergo intestinal metabolism (Usansky and Sinko, 2005) . The most popular high-throughput screening tool for drug permeability is human colon carcinoma (Caco-2) (Hidalgo et al., 1989) or transfected Madin-Darby canine kidney (Irvine et al., 1999) cells. Upon culture, Caco-2 cells differentiate and become confluent to form monolayers with tight junctions and polarized apical/mucosal (A side) and basolateral/serosal (B side) membranes that are structurally and functionally similar to those of enterocytes.
The majority of drugs available on the market are in oral dosage forms. For the assessment of permeability and oral drug absorption, in silico models (Stenberg et al., 2001 ) and high throughput systems, such as the parallel artificial membrane permeability assay (Kansy et al., 1998) and cell-based systems (Hidalgo et al., 1989) exist to relate drug permeability to absorption, especially for compounds that do not undergo intestinal metabolism (Usansky and Sinko, 2005) . The most popular high-throughput screening tool for drug permeability is human colon carcinoma (Caco-2) (Hidalgo et al., 1989) or transfected Madin-Darby canine kidney (Irvine et al., 1999) cells. Upon culture, Caco-2 cells differentiate and become confluent to form monolayers with tight junctions and polarized apical/mucosal (A side) and basolateral/serosal (B side) membranes that are structurally and functionally similar to those of enterocytes.
ABC efflux transporters such as P-glycoprotein (Pgp) multidrug resistance-associated protein 2 (MRP2), and the breast cancer-resistant protein (BCRP) are expressed on the mucosal membrane of Caco-2 (Hunter et al., 1993; Hirohashi et al., 2000) , as are the absorptive transporters, such as the proton-coupled oligopeptide transporter (PEPT1) (Guo et al., 1999) and the organic anion transporting polypeptide (OATP) (Kobayashi et al., 2003) . Likewise, on the serosal membrane, basolateral efflux transporters such as MRP3 (Hirohashi et al., 2000) and organic solute transporters ␣ and ␤ (OST␣-OST␤) (Okuwaki et al., 2007) are expressed in Caco-2. In addition, multiple metabolic enzymes such as the sulfotransferases, UDPglucuronosyltransferases (H. Sun, L. Zhang, E. C. Chow, G. Lin, K. S. Pang, Z. Zuo, unpublished data), and the glutathione S-transferases (Peters and Roelofs, 1989) reside in the Caco-2 cell monolayer. Besides, CYP3A4, which is inherently poorly expressed in the cell monolayer, may be induced by incubation with 1␣,25-dihydroxyvitamin D 3 or acquired by transfection of the CYP3A4 gene (Cummins et al., 2001 ). The Caco-2 system allows for paracellular transport (Adson et al., 1994) , and Ca 2ϩ -free buffer has often been used to disrupt paracellular transport of fluorescein, a highly fluorescent probe, for assessment of the contribution of the pathway (Troutman and Thakker, 2003a) . Furthermore, an unstirred water layer that can impede the transport of highly lipophilic drugs has been described for the Caco-2 cells (Hidalgo et al., 1991) .
Cell-based permeability models have become a necessary strategy in the drug discovery paradigm (Lentz et al., 2000; Polli et al., 2001) . The protocol facilitates the drug-discovery scenario to define whether new drug entities are Pgp substrates. Inhibitors such as GF120918 are used to obliterate apical efflux and identify Pgp involvement. In parallel, computational models have evolved to describe Caco-2 transport. However, most of the interpretations express simplified views and provide approximate solutions for the passive permeability coefficient, P app , by assuming that the system is a single barrier. Even for nonlinear cases, influx or efflux at the apical membrane was simplified by viewing the system as a single barrier and assuming that drug molecules present at either the apical or basolateral compartment have direct access to intracellular enzymes or efflux transporters (Guo et al., 1999; Williams et al., 2002; Troutman and Thakker, 2003b; Tran et al., 2004) .
We are of the view that the single-barrier model for the Caco-2 cell monolayer is inadequate and that a catenary model comprising basolateral (B), apical (A), and cellular compartments (Ito et al., 1999; Tam et al., 2003; Irie et al., 2004; González-Alvarez et al., 2005 ) is more appropriate than what routine analyses subscribe, especially under nonlinear conditions. Given the importance of the Caco-2 system in drug discovery and development, we explored properties of the catenary model to gain a mechanistically based understanding of the asymmetric observations arising from transporters, enzymes, and effective permeability under both linear and nonlinear conditions. We examined the definition of P app under "sink" and "nonsink" conditions and when the parameter was based on cumulative or timed sampling. The definition of EfR and its dependence on transport, binding, and metabolic parameters was studied. Moreover, the appropriateness of estimates of Michaelis-Menten parameters V max (as J max ) and K m (as KЈ m or KЉ m ) was investigated.
Theory
The Caco-2 Cell Model. We hereby briefly revisit the terminologies and concepts. Although we refer our terminology to the Caco-2 system, the kinetics derived may also apply to transfected cell lines or other similar, in vitro systems. The test compound is administered into the donor side, the apical or basolateral compartment, and samples are withdrawn at the alternate site (receiver side). Both sink and nonsink conditions for the Caco-2 system have been considered. Sink conditions refer to the situation in which back diffusion of drug in the receiver side to cell monolayer is negligible. Sink condition would be satisfied when the sampling is conducted within the time interval that drug concentration in the receiver side remains Ͻ10% of the loading concentration, C D,0 (Troutman and Thakker, 2003a) , or when drug in the serosal side is removed rapidly and irreversibly, leaving no chance for the drug to return back to the enterocyte. In contrast, no assumption needs to be made for nonsink conditions; there is no need to assume that drug concentrations are maintained high in the donor side but low in the receiver side and that drug molecules in the receiver side do not re-enter the cell compartment.
Definition of P app and EfR. The most common approach is to document drug appearance in the receiver side. This permeability FIG. 1. Schematic presentation of the Caco-2 cell-based system by a catenary model comprising the basolateral (baso), cell, and apical (ap) compartments. V, f, and C denote volume, unbound fraction, and the concentration of drugs of each compartment, respectively; M denotes formed metabolite(s). CL d1 and CL d2 , CL d4 , and CL d3 denote the influx and efflux and passive diffusion clearance on the basolateral and apical membrane, respectively. CL influx and CL efflux represent the transporter-mediated influx and efflux intrinsic clearances on the basolateral membrane; CL abs and CL int,sec denote transporter-mediated intrinsic clearances of absorption and efflux on the apical membrane, respectively; CL int,met is the metabolic intrinsic clearance. Under nonlinear conditions, CL influx , CL efflux , CL abs and CL int.sec , and CL int,met may be replaced by the V max /(K m ϩ C u ), where C u is the unbound drug concentration.
FIG. 2. The effective permeabilities P app according to eq. 1 for the A3 B and B3 A directions were identical when transporters and enzymes were absent: CL influx ϭ CL efflux ϭ CL int,sec ϭ CL abs ϭ CL int,met ϭ 0 and CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ϭ CL d . Note that, in the insets, P app decreased with cellular binding (f cell denotes the unbound fraction in the cell).
term, P app , defined in eq. 1, is commonly known as the apparent or effective permeability (Hilgers et al., 1990) ,
where (⌬A R /⌬t) is the rate of drug appearance in the receiver side, S is the surface area of the transwell (4.71 cm 2 for transwell of 24-mm insert diameter; Yamaguchi et al., 2000) , and C D,0 is the initial drug concentration in the donor side at time ϭ 0. When the value is based on cumulative sampling (total amount transported from time ϭ 0 up to the last sampling point), the cumulative P app is obtained. However, when the value is based on sampling at various time intervals, the incremental P app is obtained, and C D,0 denotes the donor concentration at the onset of the time interval (Youdim et al., 2003) . . The effective permeabilities P app versus time for the A3 B and B3 A directions were different when CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ϭ CL d ϭ 0.2 ml/min (A) or 0.05 ml/min (B) and the corresponding EfRs at varying apical efflux activities (CL int,sec ). All the unbound fractions were equal to unity; CL influx ϭ CL efflux ϭ CL int,met ϭ CL abs ϭ 0.
ability, when based in absence of transporters, denotes the ability of the molecule to traverse membranes by passive means. However, high passive permeability is not synonymous with high lipophilicity because hydrogen bonding or the presence of unstirred water layer for this group of compounds can delimit permeability to such an extent that the compounds would exhibit a low permeability. Usually, the purpose of transport studies in Caco-2 monolayer is to ascertain whether the test compound is a substrate of the efflux transporter, especially Pgp. The efflux ratio, or ratio of effective permeability for a drug given into B to appear in the A (B3 A) direction to that in the A3 B direction (eq. 2), is used.
Generally speaking, a value of Ͻ1.2 or 1.5 for EfR infers that only passive diffusion is involved in drug transport, whereas EfR values that greatly exceed unity suggest that test compounds are substrates of efflux transporters at the apical membrane (Lentz et al., 2000; Polli et al., 2001 ). However, the inference is less certain for highly permeable substrates, even though the compounds are Pgp substrates; rapid influx of drugs by passive diffusion or active uptake transporters on the apical membrane can overcome the effect of apical efflux (Lentz et al., 2000) .
For EfR values falling between approximately 1 and 1.5, there exists the dilemma of identifying whether the test compound is a substrate of Pgp or other efflux transporters. Methods involving use of inhibitors are thus developed. The effective permeability (P app ) in the presence of the specific inhibitors [GF120918 for Pgp and BCRP (den Ouden et al., 1996) , Ko143 for BCRP (Allen et al., 2002) , and MK571 for the MRPs (Gekeler et al., 1995) ] would be reduced to approximate values of the passive permeability (P PD ) when the transporter component is drastically reduced or totally obliterated. To avoid ambiguity in the definition of the concentration employed, the inhibitor should be added to both A and B compartments.
The absorptive quotient (AQ) (eq. 3) and the secretory quotient (SQ) (eq. 4) are introduced with administration of the inhibitor into the apical and basolateral sides (Troutman and Thakker, 2003c) . These expressions are derived from P app in absence and presence (P PD,A3B or P PD,B3A ) of inhibition.
A change in P app with inhibitors will alter the AQ and SQ values if apical efflux transporters are involved. The enhancement of the asymmetric transport of drugs in A3 B (absorptive) direction with attenuation of transport in B3 A (secretory) direction with Pgp inhibitors suggests that Pgp is involved in drug transport. The unidirectional measurements of AQ or SQ would reduce the workload in drug screening while providing reliability to bidirectional study for identification of Pgp substrates. It has been proposed that, if the AQ or SQ value is more than 0.3, the drug is considered to be a Pgp substrate (Thiel-Demby et al., 2004) . Caco-2 Cells and Enzymes. Caco-2 also houses various drug metabolizing enzymes, and the system has been used to study drug metabolism as well as the interplay between transporters and enzymes (Cummins et al., 2001 ). Metabolism in Caco-2 monolayer could modulate P app , EfR, and net efflux rates. The effects of metabolism have not been properly addressed. (B) , and CL influx /CL efflux (C), on EfR under linear conditions, based on eq. 12. All passive clearances were assumed to be equal (CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ϭ CL d ), and unbound fractions in basolateral and apical compartment were equal (f ap ϭ f baso ). For (A) and (B), CL influx ϭ CL efflux ϭ 0 at the basolateral membrane; for (B) and (C), CL d was assigned as 0.05 ml/min, respectively, and in (A) and (C), CL abs ϭ 0.
Various laboratories have used different terminologies to express the cellular metabolism within the Caco-2 cell system. One of these is the extraction ratio (ER), given by the ratio of the total amount of the metabolite (Met total ) divided by the sum of the Met total and the drug amount(s) in the receiving compartment (D R ; eq. 5) (Fisher et al., 1999) or by the sum of Met total , D R , and the drug amount(s) in the cell (D cell ) (eq. 6) (Cummins et al., 2001) .
These equations on the extraction ratio have been misconstrued to describe the extents of metabolism because the equations have ne- FIG. 6 . Influence of Pgp-mediated efflux (CL int,sec , from 0 to 5 ml/min) on the asymmetry in metabolite formation at 1-h sampling expressed as a fraction of the dose of metabolite formed, f met , from the B3 A direction versus the A3 B direction under linear conditions for solutes of (A) high (CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ϭ CL d ϭ 0.2 ml/min) or (B) low (CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ϭ CL d ϭ 0.05 ml/min) passive permeability. In all simulations, CL int,met ϭ 0.05 ml/min, CL abs ϭ 0, CL influx ϭ CL efflux ϭ 0 at the basolateral membrane, and unbound fractions were equal to unity.
glected to consider the entire mass of the system, namely, drugs in the donor and/or cell compartments in the system. The above equations have led to the misconception that metabolism can be increased with increase in efflux transport under linear conditions. A simple equation (eq. 7) that describes the fraction of dose metabolized (f met ) has been used to correct for the misconception (Tam et al., 2003) :
The parameter, f met , expressed as a fraction of dose reflects the metabolic efficiency of the system and is more appropriate to describe the extent of drug metabolism in the Caco-2 monolayer.
Nonlinearity. To understand the transport mechanism of drugs across the Caco-2 monolayer, the individual contribution of passive diffusion/permeability (P PD ) and transporters (P c ) to the overall or total permeability (P app ) has to be distinguished under nonlinear situations. The carrier-mediated permeability (P c ) has been defined as J max /(KЈ m ϩ C D,0 ) and J max /KЈ m for nonlinear and linear cases, respectively (Troutman et al., 2003b) .
KЈ m and J max are estimates of the Michaelis-Menten constant (K m ) and maximum flux (V max ) for the transporter, respectively. Usually, P c , or FIG. 7 . Effects of saturable, apical efflux (V max ϭ 50 nmol/min, K m ϭ 10 M) on the effect of permeability (P app,A3B , P app,B3A ) and efflux ratio (EfR) for a solute of high (A) and low (B) passive, diffusive clearance (CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ϭ CL d ϭ 1 or 0.05 ml/min, respectively). In all simulations, CL abs ϭ CL influx ϭ CL efflux ϭ 0, f ap ϭ f baso ϭ f cell ϭ 1, and CL int,met ϭ 0.1 ml/min; C D,0 was varied from 0.5 to 500 M to reach greater degrees of saturation of apical efflux.
the carrier-mediated permeability associated with the saturable process, is estimated from eq. 8 as P app Ϫ P PD . In the case of saturable apical efflux, P PD may be evaluated from use of inhibitors of efflux transporters. The apical, absorptive transporter or enzyme activity is usually negligible in nontransfectants (Caco-2 cells), and transporter/ metabolic activity shows up only in transfectants. Thus, P app may be evaluated from transfectants and P PD from mock-transfected Caco-2 cells (Cummins et al., 2001; Bhardwaj et al., 2005) .
Analogously, the net flux due to carrier-mediated transport (J c ) is viewed as the difference between the total flux (J) and flux due to passive diffusion (J m ) and was estimated as P c SC D,0 . These relate to the estimated parameters, J max (for V max ) and KЈ m (for K m ). In most of the investigations, it has been assumed that apical efflux is the saturable process and that substrate concentration at the vicinity of the transport process is the initial loading concentration, C D,0 .
FIG. 8. Effects of saturable, apical efflux on rates of metabolism expressed as a fraction of the dose metabolized (f met,A3 B ) and (f met,B3 A ) on the asymmetry of metabolism for a solute of high or low passive, diffusive clearance (CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ϭ CL d ϭ 1 or 0.05 ml/min, respectively); CL abs ϭ CL influx ϭ CL efflux ϭ 0, f ap ϭ f baso ϭ f cell ϭ 1, and CL int,met ϭ 0.1 ml/min. In this simulation, the K m (10 M) for apical efflux was kept constant, whereas the V max was varied from 0 to 1000 nmol/min at C D,0 ϭ 100 M.
In this "improvised method," J max was first estimated from the yintercept of the Eadie-Hofstee plot, and ␤ and KЉ m were estimated from refitting of data to eq. 11.
Materials and Methods
The Catenary Caco-2 Cell Model. A catenary model similar to those used by others (Ito et al., 1999; Tam et al., 2003; Irie et al., 2004; González-Alvarez et al., 2005) was employed to appraise various aspects of the effective permeability, efflux ratio, and data interpretation on transporters and enzymes in Caco-2 monolayers. The model comprised the absorptive and ABC transporters of the apical membrane and influx and efflux barriers at the basolateral membrane as two sets of potential barriers. The complexity of housing the ABC transporters in a lipid bilayer was not considered because the equilibrium of drug molecules between the aqueous compartment and inner/outer plasma membrane would be achieved rapidly. In addition, paracellular transport was neglected, as this could be embedded in the parameter for passive diffusion permeability.
The cell monolayer is viewed as a system that includes transporters and enzymes and allows for drug diffusion and cellular binding. The net flux associated with drug permeation in the catenary model involves two different barriers-one at the apical membrane, separating the apical compartment and cell, and the other at the basolateral membrane, separating the basolateral compartment and cell (Fig. 1) . The terms CL abs and CL d4 denote the absorptive clearance ascribed to transporter-mediation and passive diffusion on the apical membrane, respectively; CL int,sec and CL d3 denote the secretory and passive transport clearances of drug from the cell back to the apical compartment, respectively; CL d1 and CL influx represent the passive and transporter-mediated influx clearances of drug between the basolateral compartment and cell monolayer, respectively; CL d2 and CL efflux represent the passive and transportermediated efflux clearances of drug between cell monolayer and the basolateral compartment, respectively. Unless specified, it was assumed that the clearances driven by passive diffusion are equal (CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ϭ CL d ). These CL d terms relate to drug permeability by passive diffusion. A drug with high CL d is highly permeable, whereas a drug with low CL d is poorly permeable and requires transporters to facilitate transport.
In this study, simulations were conducted to produce profiles on transport and metabolism of solutes in the Caco-2 monolayer that was grown on a transwell of 24-mm insert diameter (six-well plate). V ap (1.5 ml) and V baso (2.5 ml) were the volumes of buffer solution in the apical and basolateral compartments, respectively. One popular approach to estimate the cellular volume (V cell ) is by geometrical calculation, in which V cell equals the insert area ϫ cell height. Blais et al. (1987) had measured the cell height by a pulse height analyzer and estimated V cell to be 3.66 l/mg protein. Since the protein content of a confluent Caco-2 monolayer was 3 mg (Irie et al., 2004) , the V cell was calculated to be 10.98 l (3.66 l/mg ϫ 3 mg). In the second method, Yamaguchi et al. (2000) studied sulfanilamide, a poorly protein-bound compound whose transport was mediated only by passive diffusion, and estimated V cell to be 12.15 l from the amount of sulfanilamide cumulated in the cell monolayer/external sulfanilamide concentration at equilibrium. Hence, in the present study, we took the average value of these V cell values, 11.56 l, for all simulations.
Under nonlinear conditions, the rate of solute appearance in the receiver side changed with the initial concentration in the donor side, C D,0 . These changes FIG. 9 . Effect of saturable, apical efflux (V max ϭ 0.5 nmol/min and K m ϭ 0.5 M) on (A) carrier-mediated effective permeability, P c , (B) the net flux associated with carrier (J c ) at 1-h sampling, and (C) the resulting Eadie-Hofstee plots at different loading concentrations (C D,0 ) in both A3 B (open symbols) and B3 A (solid symbols) directions, when passive diffusion [CL d : E, F (0.01 ml/min), ƒ, (0.1 ml/min), and Ⅺ, f (1 ml/min) (see inset)] was altered. The unbound fractions were all set to unity; CL int,met was set to 0.01 ml/min; CL influx ϭ CL efflux ϭ CL abs ϭ 0. Note the nonconformity of some of the data to Michaelis-Menten kinetics. Usually, the early data points were used to estimate the J max (y-intercept at J c /C D,0 ϭ 0) then the KЈ m from the slope (ϪKЈ m ) or KЉ m with an equation associated with the Hill coefficient (eq. 11).
with concentration were observed with saturation of the apical efflux (Gonzá-lez-Alvarez et al., 2005) , apical influx (Tamai et al., 1997) , basolateral influx (Irie et al., 2004) , or metabolism (H. Sun, L. Zhang, E. C. Chow, G. Lin, K. S. Pang, and Z. Zuo, unpublished data). The linear model described in Fig. 1 was modified to include nonlinearity by substitution of the clearance term of the apical or basolateral membrane with V max /(K m ϩ C u ), where C u was the unbound drug concentration and V max and K m were the maximum velocity and Michaelis-Menten constant, respectively.
For simplicity, metabolism within the system was viewed as the aggregate amount of metabolite formed that was associated with the metabolic intrinsic clearance, CL int,met . Drug binding to proteins in the apical and basolateral compartments would occur due to the presence of sloughed-off mucosal cells (unbound fractions, f ap and f baso , respectively) and within the cell (unbound fraction, f cell ). Binding would affect the mass transfer and metabolic rates that are based on unbound drug concentrations. The assumption was made that formed metabolites did not compete with the parent drug for the transporters, enzymes, and drug-protein binding. The substrate was further assumed to undergo simple Michaelis-Menten kinetics for both transport and metabolism under nonlinear conditions. Solutions and Simulations. Mass balance equations (see Appendix) based on the catenary model shown in Fig. 1 were developed. Under linear condition, the equations were solved for P app and EfR with the program Maple 9.0 (Waterloo Maple Inc., Waterloo, Canada). Computer simulations were performed under linear and nonlinear conditions with Scientist (Micromath, Salt Lake City, Utah). Different CL d , CL int,met , CL abs , CL int,sec , V max , and K m were assigned.
Results
Linear Conditions. Both sink and nonsink conditions were examined. The P app under nonsink conditions was best to describe drug Hence, further analyses only pertained to the cumulative P app . Although an explicit solution was found for P app by matrix inversion for nonsink conditions, the solution was not readily presentable because the expression was very lengthy. Instead, computer simulation was used to show patterns of P app and the factors that modulated P app . P app and EfR in Absence of Metabolic Enzyme and Transporter Activity. When transporter and enzyme activities were absent, P app was found to be time-and permeability-dependent (Fig. 2) . With the assumption that CL d ϭ CL d2 ϭ CL d3 ϭ CL d4 ϭ CL d , P app,A3B and P app,B3A profiles were found to be identical (Fig. 2) , resulting in EfR values that were constant (unity) and time-invariant. Binding within the cell further affected the P app patterns (Fig. 2, insets) , rendering decreased P app with decreasing unbound fraction, f cell . However, binding would not alter EfR, as predicted by eq. 12.
P app and EfR in the Presence of Efflux or Metabolism. P app was found to be modulated by CL int,sec (Fig. 3) at both high and low passive diffusion clearance, CL d . P app,B3A was increased, whereas P app,A3B was decreased with increasing CL int,sec ; thus, EfRs were increased, and the values were higher for drugs with low CL d (Fig. 3) . By contrast, P app values were identical in both absorptive and secretory directions, and P app decreased with increasing CL int,met (Fig. 4) ; the P app values were lower for drugs of lower CL d . Values of the resultant EfR converged at unity, regardless of values of CL int,met .
Solution for EfR. The solution for EfR existed in a concise form under linear conditions, and was similar to that reported by Adachi et al. (2001) , with the exception of the unbound fractions.
CL int,met and f cell were absent in eq. 12 for EfR. The equation implied that, under linear conditions, intracellular metabolism and the binding of drugs to intracellular protein would not influence EfR. When protein was absent (f ap ϭ f baso ϭ 1) or when binding was similar (f ap ϭ f baso ), the binding terms would disappear and the f baso and f ap terms were canceled, and eq. 12 was further simplified.
Based on eq. 13, the effect of the various clearances on EfR was investigated. The results are summarized in three-dimensional graphical presentations. As shown in Fig. 5A , values of EfR fell between 1 and 2 when the test compounds were of high CL d (ϳ1 ml/min), even when the efflux transporter activity (CL int,sec ) was substantial (0.8 ml/min). The same was observed for compounds that were actively taken up by the apical transporters (CL abs Ͼ Ͼ CL d4 ), rendering values of EfR below unity (Fig. 5B ). However, extremely high EfR values would result with increasing CL int,sec but decreasing CL d (Fig. 5A ) or CL abs (Fig. 5B) , which disallowed rapid equilibration of drug between the cellular and the apical compartment. By contrast, decreasing values of CL influx /CL efflux would furnish modest values of EfR (between 0.5 and 2) even for substrates that were readily effluxed out at the apical membrane (CL int,sec ϭ 0.9 ml/min) (Fig. 5C ).
With the assumption that CL d1 equals CL d2 , CL d3 equals CL d4 , and only apical efflux is carrier-mediated (i.e., CL abs ϭ CL influx ϭ CL efflux ϭ 0), eq. 13 was further simplified. (Lentz et al., 2000; Polli et al., 2001) . Fortunately, the ambiguity may be removed with the use of potent Pgp inhibitors that would drastically reduce the EfR, revealing AQ and SQ values that denote Pgp transport. Therefore, EfR values needed to be appraised and compared, together with other permeability data with Pgp inhibitors, such as AQ and SQ. Asymmetry of Metabolism. The amount of metabolite formed (Met total ) was normalized to the dose and expressed as f met (eq. 7). A faster metabolite formation rate was observed with apical over basolateral dosing, even with identical initial concentration administered. The observed asymmetry in metabolism resulting from administration into the apical or basolateral side was expected because of differences in volumes (V ap and V baso ). When identical permeability clearances existed across the apical and basolateral membranes (CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ) and carrier-mediated transport was absent (CL abs ϭ CL int,sec ϭ CL influx ϭ CL efflux ϭ 0), f met,B3 A /f met,A3 B was less than 1 (Fig. 6) . When V ap and V baso were equal, the metabolic asymmetry disappeared (simulation not shown). With increasing incubation time, f met,A3 B , f met,B3 A , and f met,B3 A /f met,A3 B increased and finally approached 1 (when time approached infinity in this system, all drugs ultimately became metabolized and f met in both directions equaled unity). Again, the passive diffusion clearance (CL d ) was important, and a greater permeability of the solute facilitated a faster entry of drug for cellular metabolism (Fig. 6, A and B) . Carrier-mediated [CL d : E, F (0.01 ml/min), ƒ, (0.1 ml/min), and Ⅺ, f (1 ml/min) (see inset)] was altered. The unbound fractions were all set to unity; CL int,met was set to 0.01 ml/min; CL influx ϭ CL efflux ϭ CL int,sec ϭ 0. Note the nonconformity of some of the data to Michaelis-Menten kinetics. Usually, the early data points are used to estimate the J max (y-intercept at J c /C D,0 ϭ 0) then the KЈ m from the slope (ϪKЈ m ) or KЉ m with an equation associated with the Hill coefficient (eq. 11).
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Nonlinear Conditions. Saturable terms, V max and K m , were used as replacement of the intrinsic clearances in the catenary model (Fig. 1) ; CL d1 , CL d2 , CL d3 , and CL d4 were set equal to CL d , and the unbound fractions were set to unity. For each simulation, only one saturable process (apical influx or efflux, basolateral influx or efflux, or intracellular metabolism) was considered in the Caco-2 system. Simulations were then performed to provide data for appraisal of the appropriateness of the estimates (KЈ m or KЉ m and J max ) versus the assigned K m and V max for the saturable process. The strategy generated sets of data with assigned constants (K m and V max , CL d and C D,0 ), and these were further manipulated into forms used in data interpretation. The true values and the derived estimates were then compared. First, the manner in which saturation of apical efflux transporters affected P app and EfR at increasing C D,0 was examined. Solutes with high CL d entered the cell compartment rapidly and readily saturated apical efflux with increasing C D,0 . Values of P app,A3B increased with C D,0 (Fig. 7, top panel) , whereas P app,B3A decreased with C D,0 (Fig.  7, middle panel) . These resulted in attenuated EfRs (Fig. 7, bottom   FIG. 12 . Correlation between estimated parameter J max at 1-h sampling versus the assigned V max (A, B, and C) and KЈ m and KЉ m versus the assigned K m (D, E, and F) for the absorptive, apical transporter in the Caco-2 cell monolayer (data of Tables 3 and 4) when different CL d (0.01, 0.1, and 1 ml/min) were used for simulation. D-F, KЈ m (EF) and KЉ m (ƒ) estimates are plotted against the true K m . Transport in A3 B and B3 A directions was denoted by open and solid symbols, respectively. For the simulations, all the unbound fractions were set to unity; CL influx ϭ CL efflux ϭ CL int,sec ϭ 0; CL int,met ϭ 0.01 ml/min. panel). By contrast, less changes for P app,A3B and P app,B3A were found for drugs of low CL d because these failed to enter the cell readily to saturate apical efflux transporters. Second, the effect of saturable apical efflux on metabolism was considered. The presence of apical efflux reduced the fraction of dose metabolized, f met , since efflux was competing with metabolism. An increase in V max for apical efflux also reduced f met , regardless of whether the drug was given to A or B, and this existed when the drug equilibrated rapidly (Fig. 8A) or slowly (Fig. 8B) .
Eadie-Hofstee Plot. Characteristic profiles were obtained upon plotting P c (eq. 8) and J c (eq. 9) against C D,0 (Figs. 9, A and B) when saturable efflux existed. A lack of conformity to linearity was commonly observed with the Eadie-Hofstee plot for the estimation of KЈ m and J max (flux versus flux/C D,0 ) (Fig. 9C) . Usually, the intercept and slope of the plot associated with the straight line component would be used for estimation of J max and KЈ m , respectively (see straight line in inset, Fig. 9C , for drug of high CL d ). Poor estimates would result when curvature existed in the Eadie-Hofstee plot for solutes of low CL d (Ͻ1 ml/min). When eq. 10 was used to improve the fit with the Hill coefficient, ␤, KЉ m , estimated from refitting of data to eq. 11, was not much improved compared with KЈ m (see below). The estimate of J max remained unchanged since the parameter was estimated from the y-intercept of the Eadie-Hofstee plot.
Estimation of Parameters: Nonlinear Apical Efflux. With varying CL d (0.01, 0.1, or 1 ml/min), further simulations were performed with varying V max (0.05 to 50 nmol/min) at a fixed K m (0.5 M) for (Tables 1 and 2 ). The early data points of the Eadie-Hofstee plots were used to estimate the J max and KЈ m from the intercept and slope, respectively (Fig. 9C) . A linear relationship was observed for the Eadie-Hofstee plot only with higher CL d (Fig.  9C, inset) . Upon presenting the entire set of estimates, it was apparent that J max differed from the assigned V max and varied according to the value of CL d ( Fig. 10 ; Table 1 ). The correlation was poor at low CL d (0.01 ml/min), whereas an improved and linear correlation was identified at increasing CL d (Ն1 ml/min) (Fig. 10, A-C) . The estimated KЈ m and KЈ m were less affected by CL d . Linear relationships were found between KЈ m and KЉ m and the assigned K m (Fig. 10, D-F) ; the values became closest when CL d was highest (Table 2 ). However, no further improvement was provided with use of eq. 10 or eq. 11 to arrive at KЉ m (Table 2 ; Fig. 10 , D-F). Estimation of Parameters: Nonlinear Apical Absorption. With varying CL d (0.01, 0.1, or 1 ml/min), simulations were performed with varying V max (0.05 to 50 nmol/min), but at a fixed K m (0.5 M), and at varying K m (from 0.5 to 50 M) but at a fixed V max (0.5 nmol/min) for the apical absorption transporter to arrive at sets of P c and J c data (Fig. 11) . With saturable apical absorption, higher P c and J c values were obtained in the B3 A and not A3 B direction, except for drugs of a very low CL d (Fig. 11, A and B) . Again, curvatures were observed for the Eadie-Hofstee plot, except for drugs of high CL d (Fig. 11C, inset) . The estimated J max was poorly correlated to the V max , especially when CL d was lower (Fig. 12 , A-C; Table 3 ), but a linear correlation between J max and V max was attained when CL d values were high (Fig. 12C) . The correlation between KЈ m and KЉ m to K m was acceptable among the various CL d (Fig. 12, D-F ; Table 4) , and an improved correlation existed when the CL d values were high (Fig. 12F) . Again, no further improvement was demonstrated with use of eq. 10 or eq. 11 to arrive at KЉ m (Table 4 ; Fig. 12, D-F) .
Estimation of Parameters: Nonlinear Metabolism. With varying CL d (0.01, 0.1, or 1 ml/min), simulations were performed with varying V max (0.05 to 50 nmol/min) at a fixed K m (0.5 M) for the metabolism and at varying K m (0.05 to 50 M) at a fixed V max (0.5 nmol/min) to arrive at sets of P c and J c data (Fig. 13) . With saturable metabolism, values of P c were higher with higher CL d (Fig. 13A ). Higher J c values were observed in the A3 B but not B3 A direction (Fig. 13B) , yielding correspondingly higher V max (y-intercept) (Fig. 13C) . The correlation between J max and V max was poor regardless of values for CL d (Fig. 14, A-C; Table 5 ). By contrast, a linear correlation was found between KЈ m and KЉ m with K m among the various CL d (Fig. 14, D-F ; Table 6 ); the correlation improved when CL d values were high. Again, no further improvement was provided with use of eq. 10 or eq. 11 to arrive at KЉ m (Table 6 ; Fig. 14, D-F) .
Sampling Time. Sampling in the Caco-2 system was often performed at 1-or 2-h intervals. However, the manner in which sampling time affected the J c estimates was seldom studied. We examined how sampling time affected estimation of P c and J c within the sets of simulations performed on saturation of apical efflux, apical absorption, and metabolism. Indeed, the sampling time affected values of J c , although saturation profiles were retained versus C D,0 in both A3 B and B3 A (Fig. 15) . Hence, the general shapes were retained for all of the Eadie-Hofstee plots, but estimates for KЈ m and J max would change when the sampling time, whether 0.5, 1, or 2 h, was used (data not shown).
Effect of Nonlinear Metabolite Formation. Simulation was performed to examine how the various saturable processes affected metabolite formation. For drugs of high CL d (1 ml/min), saturable apical efflux (Fig. 16A) , apical absorption (Fig. 16B) , basolateral efflux (Fig. 16C) , and basolateral influx (Fig. 16D ) resulted in asymmetric metabolite formation, namely, higher for the secretory direc- [CL d : E, F (0.01 ml/min), ƒ, (0.1 ml/min), and Ⅺ, f (1 ml/min)] was altered. The unbound fractions were all set to unity; CL influx ϭ CL efflux ϭ CL abs ϭ CL int,sec ϭ 0. Note the nonconformity of some of the data to Michaelis-Menten kinetics. Usually, the early data points are used to estimate the J max (y-intercept at J c /C D,0 ϭ 0) then the KЈ m from the slope (ϪKЈ m ) or KЉ m with an equation associated with the Hill coefficient (eq. 11).
tion over the absorptive direction. The trend was partially due to the higher volume of the basolateral compartment; the dose V baso C D,0 was larger than V ap C D,0 . Patterns for metabolite formation under saturable apical efflux (Fig. 16A ) and basolateral efflux (Fig. 16C) were similar; lesser metabolism was observed with higher V max s to bring drug molecules out of the cell. The cumulative amount of metabolite formed was time-dependent (Fig. 16) . In addition, similar patterns existed between the profiles of metabolite formation for saturable absorption or basolateral influx; greater extents of metabolism were found associated with higher V max , since this tended to bring more drug molecules into the cell (Figs. 16, B and D) . For drugs of poor diffusion clearance (CL d ϭ 0.01 ml/min), greater amounts of metabolite formed were seen in the B3 A direction, except when the apical transporter was present (Fig. 16F) . At low CL d , drug transport into and out of the cell would be nominal, unless there was enhanced apical absorption by transporters, rendering a greater extent of metabolism in the A3 B direction; the trend intensified with increased V max for the absorptive transporter (Fig. 16F) .
When metabolite formation (at 1 h) was further examined at increasing C D,0 , a trend indicating higher metabolite formation for the B3 A direction over the A3 B direction was unilaterally observed (Fig. 17, A-D) , regardless of the saturable process (apical efflux, FIG. 14. Correlation between estimated parameter J max at 1-h sampling versus the assigned V max (A, B, and C) and KЈ m and KЉ m versus the assigned K m (D, E, and F) for saturable cellular metabolic activity in the Caco-2 cell monolayer (data of Tables 5 and 6) when different CL d (0.01, 0.1, and 1 ml/min) were used for simulation. Transport in A3 B and B3 A directions was denoted by open and solid symbols, respectively. In (B), KЈ m and KЉ m were represented by E, F and ‚, OE, respectively. For the simulations, all the unbound fractions were set to unity; CL influx ϭ CL efflux ϭ CL abs ϭ CL int,sec ϭ 0.
at ASPET Journals on August 27, 2017 dmd.aspetjournals.org Downloaded from apical absorption, basolateral influx, or basolateral efflux). The cumulative amount of metabolite formed was less with higher V max associated with saturable apical efflux (Fig. 17A ) and saturable basolateral efflux (Fig. 17C) , and opposite trends existed with saturation of apical absorption and basolateral influx (Fig. 17, B and D) . For drugs of poor diffusion clearance (CL d ϭ 0.01 ml/min), higher metabolite formation was again seen in the B3 A direction, except when apical absorptive transport was present (Fig. 17F) . At low CL d , transport into and out of the cell would be nominal unless there was enhanced absorption by transporters, rendering more metabolism in the A3 B direction. The trend intensified when the V max for the absorptive transporter was increased (Fig. 17F) .
Effect of Nonlinear Processes on EfR. Patterns of EfR under nonlinear conditions were examined. In these simulations, the saturable component was assigned a V max of 0.5 nmol/min and K m of 0.5 M, and CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ϭ CL d . EfR values differed with saturable apical efflux and metabolism (Ͼ1) and apical absorption (EfRs Ͻ1) but approached unity with high CL d and increasing C D,0 at a higher degree of saturation of the process. Saturable apical efflux (Fig. 18A ) resulted in EfR values that exceeded unity but approached unity at high C D,0 when the apical efflux transporter was becoming saturated. Similar to the linear case, lower EfR values were found at higher CL d . A reverse trend was observed for saturable apical influx, showing EfR values below unity (Fig. 18B) ; increasingly higher EfRs resulted with higher CL d and C D,0 . With saturable metabolism, an upswing then downswing pattern was observed for EfR with C D,0 , and the changes were more pronounced for higher CL d (Fig. 18C) . For saturable apical efflux, influx, and metabolism, rapid drug entry by passive diffusion (high CL d ) counteracted the effects of the saturable process on EfR. Eventually, the EfR values returned to unity when the apical efflux, absorptive, or metabolic process failed to contribute significantly to the system with increasing C D,0 , as if only passive diffusion prevailed under linear conditions ( Fig. 5 ; eq. 12). Other Simulations. Other scenarios such as saturation of basolateral influx or basolateral efflux were not examined. This was because the patterns generated would be similar to those simulated for saturation of apical influx and apical secretion (mirror images for donor versus receiver side), although minor differences would exist due to differences in volumes (V ap and V baso ).
Discussion
The Caco-2 system has become the gold standard to relate drug permeability to oral drug absorption (Hidalgo et al., 1989; Lentz et al., 2000; Polli et al., 2001; Thiel-Demby et al., 2004) . Due to the prevalent use, a thorough examination in revisiting the terminologies used in literature and data interpretation in the Caco-2 monolayer is therefore justified. Equation 1 was established under Fick's law to define drug permeability, P app , with the assumptions that the driving force is the concentration gradient difference and a single barrier exists for the Caco-2 monolayer (Hilgers et al., 1990) . Although P app is a time-dependent variable and higher P app is associated with higher CL d , the ratio of P app (P app,B3A /P app,A3B ) yields a meaningful EfR that is time-independent and CL d -invariant when transporter activity is absent.
The meaning of EfR under linear conditions was further clarified by eq. 12. As shown in eq. 12, EfR is dependent not only on the apical, secretory intrinsic clearance (CL int,sec ) but also on the relative magnitude of passive diffusion and transport clearances at the basolateral membrane (CL d1 ϩ CL influx )/(CL d2 ϩ CL efflux ), CL d3 and CL d4 , and the apical absorptive clearance CL abs . Hence, the value of EfR may not always identify whether a test compound is a Pgp substrate. For drugs of rapid uptake clearances at the apical membranes, values of EfR are reduced by high CL d4 (eq. 14) or CL abs values (Fig. 5) ; the asymmetrical influx and efflux on basolateral membrane (CL influx / CL efflux ) can also modulate the EfR. The same comment was made by Adachi et al. (2001) . Even with the simplification that CL abs ϭ 0 and all diffusive clearances are identical (CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ), values of EfR may still hover around unity for drugs whose diffusion clearance (CL d4 ) is high in relation to that of the secretory clearance (eq. 14) (Lentz et al., 2000) .
In addition, EfR will be affected differentially by secretion and metabolism under linear conditions. Pgp-, BCRP-, or MRP2-mediated efflux tends to provide higher EfR values when CL int,sec Ͼ Ͼ CL d and when the passive diffusion clearance (CL d ) is low, rendering asymmetry in permeability from the B3 A direction over the A3 B direction (Fig. 3) . For solutes of high CL d , ambiguous EfR values (close to unity) may result unless CL int,sec is extremely high (Fig. 3A) . The possibility that the compound is a Pgp substrate needs to be clarified with use of inhibitors by the AQ and SQ (eqs. 3 and 4). For solutes with low CL d , higher EfR values will result as a consequence of secretion for Pgp substrates (Fig. 3B) . By contrast, EfR is not affected by metabolism; the metabolic intrinsic clearance affects P app in the B3 A and A3 B directions to the same extent, thereby EfR remains unchanged (Fig. 4) . The extent of metabolite formation in the A3 B direction is higher than that in the B3 A direction. The pattern is inherently asymmetric simply because of unequal V ap and V baso , and metabolite formation is reduced by apical secretion in both directions (Fig. 6) .
Saturation of transport and metabolic processes, however, will be encountered with increasing drug loading concentration within the Caco-2 cell system. The biggest disappointment in other existing data interpretation strategies lies in treating the Caco-2 cell system as a single barrier for parameter estimates of saturable processes. Even when perfect data for P c and J c are attainable with use of "specific" inhibitors that completely block the secretory process, or when transport/metabolic activities are associated only with transfected but not mock-transfected cells to enable precise measurements, the J max and KЈ m estimates are far from the true values (Tables 1-6 ). The method, based on the assumption that the Caco-2 cell system is a single barrier, will yield inappropriate estimates.
In addition, the time of sampling (Fig. 15) , the passive permeability of drug, tissue binding, and metabolism, and the parameter space of K m and V max strongly influence both the correlation and accuracy of prediction. Saturation in apical absorption, efflux, or metabolism in the Caco-2 system results in similar Eadie-Hofstee plots for the receiver side that show nonconformity to simple Michaelis-Menten kinetics (Figs. 9C, 11C, and 13C ). The net flux is a consequence of multiple processes involving more than a single barrier, and C D,0 cannot estimate the substrate concentration in the vicinity of the transporter or enzyme. The estimated J max is poorly correlated to the true V max , especially for substrates of low diffusive clearance (CL d Ͻ 1 ml/min); the observation persists when apical influx, secretion, or cellular metabolism is the saturable process (Figs. 10, 12 , and 14, A-C; Tables 1, 3 , and 5). J max is correlated with the true V max only for solutes of high CL d for apical secretion and absorption but not for cellular metabolism (Figs. 10C, 12C, and 14C ). An improved correlation is also observed with reduction of assigned values of V max (Ͻ20 nmol/min) or increased values of C D,0 for simulation (data not reported). By contrast, a linear correlation is found between the estimated KЈ m or K Љ m and K m when apical influx, secretion, or cellular metabolism is the saturable process (Figs. 10, 12 , and 14, D-F; Tables 2, 4, and 6). The finding is in contrast to that of Bentz et al. (2005) , who commented that a better correlation existed between J max and V max and not KЈ m or K Љ m and K m . The correlation is again dependent on values of CL d , since drugs with higher CL d equilibrate faster between the donor, cellular, and receiving sites, rendering improvement in the correlation (Figs. 10, 12 , and 14; Tables 1-6). K Љ m , the parameter obtained by fitting P c to the Hill-equation-like formula, fails to furnish additional physical meaning or improvement over KЈ m in the correlation with K m . The existence of correlation between effective and true parameters (J max versus V max and KЈ m or K Љ m versus K m ) is useful (Figs. 10, 12 , and 14), since changes in J max or KЈ m (e.g., induction or inhibition) would commensurate with those of V max or K m , rendering useful interpretation on inhibition or induction of transporter or enzyme in the Caco-2 cell system.
For the description of added complexities such as carrier-mediated transport, intracellular metabolism, and saturation of the above processes, we propose use of the catenary model ( Fig. 1) for proper data interpretation in the Caco-2 system. The presentation of mass transfer (Appendix) in this kinetic model had allowed us to simulate data over time to conduct a thorough theoretical examination on transport and metabolism. Through this exercise, we obtained analytical solutions for EfR under linear conditions and examined the effects of transport and metabolic intrinsic clearances (CL d1 , CL d2 , CL d3 , CL d4 , CL int,sec , CL abs , and CL int,met ). Moreover, the model yielded data on P c , P PD , and J c under nonlinear conditions for illustration with the Eadie-Hofstee plots. Although saturation of the basolateral influx or efflux process was not simulated, these patterns could be inferred because the data would be mirror images of saturable apical influx and efflux. For the first time, trends in EfR according to CL d and C D,0 with varying saturable processes were shown (Fig. 18) ; EfR values greater than unity would not conclusively reflect involvement of apical efflux transporters since the same trends were observed with saturation in metabolism (Fig. 18C) . Although we had not explored a wide parameter space, the analyses showed that the single barrier model for the Caco-2 cell monolayer was inadequate to provide sound estimates of V max and K m of saturable systems.
The usefulness of the catenary model has been demonstrated fully by the present analysis. In this model, the timed samples collected are utilized fully for data fitting. However, due to the large number of parameters to be ascertained and saturation of one or more of the processes, the fit of the timed-metabolite data may FIG. 18 . Modulation of the efflux ratio estimated at 1 h for sampling by saturable apical efflux (A), apical influx (B), and intracellular metabolism (C). The value of EfR ϭ 1 is denoted by the dotted line. In (A) and (B), CL int,met ϭ 0.01 ml/min. Only one saturable component (V max ϭ 0.5 nmol/min and K m ϭ 0.5 M) was present at a time. For simulation, the following assumptions were made: CL d ϭ CL d1 ϭ CL d2 ϭ CL d3 ϭ CL d4 ϭ 0.01, 0.1, or 1 ml/min; all the unbound fractions equaled unity.
PERMEABILITY, TRANSPORT, AND METABOLISM IN Caco-2
at ASPET Journals on August 27, 2017 dmd.aspetjournals.org not always lead to fruitful outcomes. The usual strategy is to add the total amount of formed metabolite (amount in cell ϩ donor ϩ receiver compartments) to describe metabolism in the fitting procedure. Additional data on metabolite transport or metabolic data are absolutely necessary and would greatly add to the accuracy of the fit. The model was able to describe saturable efflux (Ito et al., 1999) , saturable apical absorption, and basolateral influx (Irie et al., 2004) , and recently, saturable metabolism and substrate inhibition (H. Sun, L. Zhang, E. C. Chow, G. Lin, K. S. Pang, and Z. Zuo, unpublished data). Proper data interpretation with the catenary model would definitely remove the bias in parameter estimates, avoid viewing the Caco-2 cell monolayer as a single barrier, and provide accurate estimates.
Appendix Mass Balance Equations in Caco-2 Cell Monolayer for Linear Conditions
In the apical compartment: 
In the cellular compartment:
V cell dC cell dt ϭ ͑CL abs ϩ CL d4 ͒f ap C ap ϩ ͑CL d1 ϩ CL influx ͒f baso C baso Ϫ ͩ CL int,sec ϩ CL d3 ϩ V max K m ϩ f cell C cell ϩ CL d2 ϩ CL effluxͪ f cell C cell (25) In the basolateral compartment:
V baso dC baso dt ϭ ͑CL d2 ϩ CL efflux ͒f cell C cell Ϫ ͑CL d1 ϩ CL influx ͒f baso C baso (26) 
